Changes in Menstrual Cycle
Jan 13, 2022
Are you experiencing changes in your menstrual cycle after getting the Covid-19 vaccine? [link] The CEO of Club Menopause (CM), Dr. Leslie Hewitt who is a retired Chiropractor says, “I don’t like hearing that post-vaccine symptoms are being normalized”.
A new study in the Obstetrics & Gynecology Journal on January 5, 2022 assessed whether coronavirus disease 2019 (COVID-19) vaccination is associated with changes in cycle or menses length in those receiving vaccination as compared with an unvaccinated cohort. Women have been reporting changes in their period after the COVID-19 vaccine.
The study confirmed at least one of these changes is “normal” post COVID-19 vaccination. Vaccinated women with periods have been reporting longer periods, missed periods and heavier periods. Postmenopausal women are reporting the return of their period. The medical community agrees there has been a lack of large-scale clinical research examining what happens with women’s menstrual cycles after the COVID-19 vaccine.
Another flaw in collecting women’s data has always been an issue says Dr. Hewitt, and that is the lack of diversity in the cross-section of women including women of color, culture, weight, and education to name a few very important data points. The data has a very important drawback because the set of women population tend to be white, educated, and thinner than the average American woman making it difficult to draw generalized conclusions.
In summary, the study is a step in the right direction understanding how the COVID-19 vaccine and vaccines in general impact periods. It’s clear that menopause needs more research and the CEO of Club Menopause and the CM Board of Advisors intend to keep an eye on the research as it rolls out. In fact, we are positioning ourselves to invest in more research because the current research being done now is missing the cross-section of women in all sectors of the psychosocioeconomic demographic defined as interventions that address any of the psychological, social, or economic problems faced by menopausal women with the goal of improving either quality-of-life or treatment outcomes.
